Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Head and Neck Cancer

Free Subscription Articles published in Am J Surg Retrieve available abstracts of 35 articles: HTML format

Single Articles

October 2025
1. ZHANG G, Chen Y, Jin D, Sui Z, et al
   Postoperative survival evaluation of patients with Siewert II adenocarcinoma of esophagogastric junction: a population-based study.
   Am J Surg. 2025;248:116536.
   PubMed     Abstract available
   
   
   
2. DONE JZ, Helbing A, Stemme R, Foote D, et al
   Higher Distressed Communities Index is associated with more aggressive features in papillary thyroid cancer.
   Am J Surg. 2025;248:116520.
   PubMed     Abstract available
   
   
   
3. MONREAL AJ, Eze AN, Thomas SM, Johnson KS, et al
   Exploring actionable targets to address disparities in thyroid cancer survival: A study of patients with aggressive variants of papillary thyroid cancer.
   Am J Surg. 2025;248:116428.
   PubMed     Abstract available
   
   
   
4. LAURIE BD, Thomas E, Nguyen H, Ryan S, et al
   FDG-avid thyroid nodules are at a significantly increased risk of malignancy.
   Am J Surg. 2025;248:116400.
   PubMed     Abstract available
   
   
   September 2025
5. FINNERTY BM, Marshall T, Annesi CA, Zarnegar R, et al
   Thyroid-stimulating immunoglobulin is not associated with aggressive clinicopathologic features in concomitant Graves' disease and papillary thyroid cancer.
   Am J Surg. 2025;247:116487.
   PubMed     Abstract available
   
   
   
6. AKINYEMI O, Weldeslase T, Fasokun M, Eze O, et al
   Medicaid expansion and thyroid cancer stage at presentation: A comparative study of two US states.
   Am J Surg. 2025;247:116447.
   PubMed     Abstract available
   
   
   August 2025
7. DING Y, Feng Z, Cao K
   Total thyroidectomy does not improve survival for all patients with unilateral papillary thyroid cancer exceeding 4 ?cm.
   Am J Surg. 2025;246:116395.
   PubMed     Abstract available
   
   
   May 2025
8. AMERI K, Kwon M, Watanabe A, Wiseman SM, et al
   Thyroid cancer quality of care indicators: A scoping review.
   Am J Surg. 2025;243:116223.
   PubMed     Abstract available
   
   
   March 2025
9. RAMESH S, Fisher JC, Curcio P, Rothberger GD, et al
   Malignancy risk associated with radioactive iodine therapy for Graves' disease.
   Am J Surg. 2025;241:116075.
   PubMed     Abstract available
   
   
   
10. RYU YJ, Hsu SY, Kuo EJ, Liou R, et al
    Radiofrequency ablation of Bethesda category III thyroid nodules with benign molecular testing: Preliminary findings from a single institution.
    Am J Surg. 2025;241:115929.
    PubMed     Abstract available
    
    
    February 2025
11. ZMIJEWSKI P, Nwaiwu C, Nakanishi H, Farsi S, et al
    Racial disparities in thyroid cancer outcomes: A systematic review.
    Am J Surg. 2025;240:115991.
    PubMed     Abstract available
    
    
    January 2025
12. BARRIO MJ, Pozdeyev N, McIntyre RC Jr, Albuja-Cruz MB, et al
    Long term outcomes after repeat lymph node dissections for persistent or recurrent differentiated thyroid cancer.
    Am J Surg. 2025;239:116045.
    PubMed     Abstract available
    
    
    December 2024
13. MARSHALL TE, Ibrahim R, Lee-Saxton YJ, Tumati A, et al
    Disparities in postoperative adjuvant therapy utilization and factors impacting survival among anaplastic thyroid cancer patients.
    Am J Surg. 2024;238:115944.
    PubMed     Abstract available
    
    
    
14. COGUA LM, Tupper CJ, Silberstein PT, Coan KE, et al
    Intermediate-sized follicular thyroid cancer surgical trends before and after the 2015 American thyroid association guideline changes.
    Am J Surg. 2024;238:115830.
    PubMed     Abstract available
    
    
    
15. BARRIO MJ, Pozdeyev N, Raeburn CD, McIntyre RC Jr, et al
    Pre-operative thyroglobulin measurement for thyroid cancer risk of recurrence and response to therapy.
    Am J Surg. 2024;238:115818.
    PubMed     Abstract available
    
    
    November 2024
16. CHAN SJ, Betcher MC, Kuo EJ, McManus CM, et al
    Trends in thyroid function following radiofrequency ablation of benign, nonfunctioning thyroid nodules: A single institution review.
    Am J Surg. 2024;237:115793.
    PubMed     Abstract available
    
    
    October 2024
17. ROSSI L, De Palma A, Ambrosini CE, Fregoli L, et al
    Histologic parameters driving completion thyroidectomy for papillary thyroid carcinoma in a high-volume institution: A retrospective observational study.
    Am J Surg. 2024;239:116016.
    PubMed     Abstract available
    
    
    August 2024
18. SU MW, Beck TN, Knepprath J, Romero-Velez G, et al
    Primary thyroid lymphoma: A multi-center retrospective review.
    Am J Surg. 2024;237:115927.
    PubMed     Abstract available
    
    
    
19. MONREAL A, Eze AN, Kazaure HS
    Presentation and management of medullary thyroid cancer by sex and race/ethnicity in the United States-A state of disunion.
    Am J Surg. 2024;234:17-18.
    PubMed    
    
    
    
20. GILLIS A, Zmijewski P, Mcleod MC, Lindeman B, et al
    Racial implications of time to surgery in disparities in thyroid cancer survival.
    Am J Surg. 2024;234:85-91.
    PubMed     Abstract available
    
    
    
21. KALVA S, Ginzberg SP, Passman JE, Soegaard Ballester JM, et al
    Sex differences and racial/ethnic disparities in the presentation and treatment of medullary thyroid cancer.
    Am J Surg. 2024;234:19-25.
    PubMed     Abstract available
    
    
    July 2024
22. BROEKHUIS JM, Gartland RM
    More than meets the size: Evaluating guideline impact on extent of surgery for follicular thyroid carcinoma.
    Am J Surg. 2024 Jul 26:115863. doi: 10.1016/j.amjsurg.2024.115863.
    PubMed    
    
    
    
23. ABRAHAM PJ, Wu C, Wang R, Herring B, et al
    The overtreatment of papillary thyroid microcarcinoma in the community.
    Am J Surg. 2024;233:132-135.
    PubMed     Abstract available
    
    
    
24. BECK TN, Romero-Velez G, Noureldine SI, Plitt G, et al
    Bilateral exploration in primary hyperparathyroidism: Double adenoma distribution and biochemical patterns over two decades.
    Am J Surg. 2024;233:61-64.
    PubMed     Abstract available
    
    
    June 2024
25. LI R, Luo Q, Gutierrez ID
    Asian Americans have higher 30-day surgical complications after esophagectomy: A propensity-score matched study from ACS-NSQIP database.
    Am J Surg. 2024;232:75-80.
    PubMed     Abstract available
    
    
    April 2024
26. NABATA KJ, Lim R, Leong R, Wiseman SM, et al
    To infinity and beyond: A historical bibliometric analysis of medullary thyroid carcinoma.
    Am J Surg. 2024 Apr 15:S0002-9610(24)00199-5. doi: 10.1016/j.amjsurg.2024.
    PubMed     Abstract available
    
    
    March 2024
27. LEONG D, Leslie C, Laurie B, Hou L, et al
    Tumour size predicts risk of recurrence in tall cell subtype papillary thyroid carcinoma.
    Am J Surg. 2024 Mar 26:S0002-9610(24)00184-3. doi: 10.1016/j.amjsurg.2024.
    PubMed     Abstract available
    
    
    
28. INNES AM, van Galen P
    Insights from the hereditary endocrine clinic.
    Am J Surg. 2024;229:203-204.
    PubMed    
    
    
    
29. HERRERA M, Hussein MH, Persons E, Alias MR, et al
    Survival benefits of extensive surgery in patients with papillary thyroid microcarcinoma.
    Am J Surg. 2024;229:99-105.
    PubMed     Abstract available
    
    
    
30. TRAN A, Weigel RJ, Beck AC
    ATA risk stratification in papillary thyroid microcarcinoma has low positive predictive value when identifying recurrence.
    Am J Surg. 2024;229:106-110.
    PubMed     Abstract available
    
    
    February 2024
31. SMITH ER, Frye CC, Pandian TK, Gillanders WE, et al
    Molecular characteristics of isthmus papillary thyroid cancers: Supporting evidence for unfavorable clinical behavior.
    Am J Surg. 2024;228:146-150.
    PubMed     Abstract available
    
    
    
32. MONTGOMERY KB, Fazendin JM, Chen H, Broman KK, et al
    Contemporary trends in extent of surgery for differentiated thyroid cancer with extrathyroidal extension.
    Am J Surg. 2024;228:173-179.
    PubMed     Abstract available
    
    
    August 2023
33. KUO LE, Suh I
    Can we improve preoperative staging for thyroid cancer?
    Am J Surg. 2023;226:170.
    PubMed    
    
    
    
34. K SAH R, Mayilvaganan S
    "Primary hyperparathyroidism after radioactive iodine therapy. Is it a distinct clinical entity?".
    Am J Surg. 2023;226:296.
    PubMed    
    
    
    
35. SOEGAARD BALLESTER JM, Finn CB, Ginzberg SP, Kelz RR, et al
    Thyroid cancer pathologic upstaging: Frequency and related factors.
    Am J Surg. 2023;226:171-175.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.